Sienna Biopharmaceuticals

About:

Clinical development and commercialization of innovative aesthetics and medical dermatology products based on scientific breakthroughs

Website: http://siennabio.com/

Twitter/X: siennabio

Top Investors: Fidelity, ARCH Venture Partners, Omega Funds, Two River, Altitude Life Science Ventures

Description:

Sienna Biopharmaceuticals (“sienna”) is a company focused on the discovery, clinical development and commercialization of products in aesthetics and dermatology based on scientific breakthroughs that dramatically improve patient outcomes and physicians’ practice of medicine.

Total Funding Amount:

$86M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Westlake Village, California, United States

Founded Date:

2010-01-01

Founders:

Geoffrey von Maltzahn

Number of Employees:

11-50

Last Funding Date:

2018-08-03

IPO Status:

Public

Industries:

© 2025 bioDAO.ai